Answers are grounded in this paper and cite their sources.
Case Reports1 January 1950THE PULMONARY MANIFESTATIONS OF SCLERODERMA: AN ANATOMIC-PHYSIOLOGICAL CORRELATIONDAVID M. SPAIN, M.D., ALBERT G. THOMAS, M.D.DAVID M. SPAIN, M.D., ALBERT G. THOMAS, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-32-1-152 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDiffuse visceral changes occurring in scleroderma have been described by Lewin and Heller,1Notthafft,2Kraus,3Klemperer, et al.,4Bevans,5and Weiss et al.6In some of these cases changes have been noted in the lungs. In most of them, however, the pulmonary findings were not a prominent clinical feature. Among the more detailed reports of lung changes in scleroderma, the review by Matsui7is noteworthy. Murphy, Krainin and Gerson8reported the first case in which pulmonary changes of scleroderma were diagnosed roentgenographically during life. This was done on the basis of diffuse reticular infiltrations in the lung associated with the...Bibliography1. LewinHeller GRJ: Die Sclerodermie, 1895, A. Hirschwald, Berlin. Google Scholar2. Von Notthafft A: Neuere Arbeiten und Ansichten ueber Sklerodermie, Centralbl. f. allg. Path. 9: 870, 1898. Google Scholar3. Kraus EJ: Zur Pathogenese der diffusen Sklerodermie, Virchows Arch. f. path. Anat. 253: 710, 1924. CrossrefGoogle Scholar4. KlempererPollackBaehr PADG: Diffuse collagen disease, J. A. M. A. 119: 331-332, 1942. CrossrefGoogle Scholar5. Bevans M: Pathology of scleroderma, with special reference to the changes in the gastro-intestinal tract, Am. J. Path. 21: 25-51, 1945. MedlineGoogle Scholar6. WeissSteadWarrenBailey SEAJVOT: Scleroderma heart disease, Arch. Int. Med. 71: 749-776, 1943. CrossrefGoogle Scholar7. Matsui S: Ueber die Pathologie und Pathogenese von Sclerodermia universalis, Mitt. a. d. med. Fak. d. k. Univ. Tokyo 31: 55-116, 1924. Google Scholar8. MurphyKraininGerson JRPMJ: Scleroderma with pulmonary fibrosis, J. A. M. A. 116: 499-501, 1941. CrossrefGoogle Scholar9. Getzowa S: Cystic and compact pulmonary sclerosis in progressive scleroderma, Arch. Path. 40: 99-106, 1945. Google Scholar10. CournandBaldwin AE: Personal communication, to be published. Google Scholar11. Dostrovsky A: Progressive scleroderma of the skin with cystic sclerodermal changes of the lungs, Arch. Dermat. and Syph. 55: 1-15, 1947. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Received for publication April 1, 1948.From the Laboratories of Pathology, Bellevue Hospital, and Chest Division, Bellevue Hospital (Columbia University, College of Physicians and Surgeons). PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II CohortPredictors of Pulmonary Hypertension on High-resolution Computed Tomography of the Chest in Systemic Sclerosis: A Retrospective AnalysisScleroderma Lung DiseaseThe natural course of progressive systemic sclerosis patients with interstitial lung involvementMANIFESTATIONS OF SCLERODERMA PULMONARY DISEASEBRONCHIOLITIS IN ASSOCIATION WITH CONNECTIVE TISSUE DISORDERSThe pulmonary pathologic manifestations of the CREST syndromePulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearanceD-penicillamine therapy and interstitial lung disease in scleroderma. a long-term followup studyThe cardiovascular manifestations of systemic sclerosis (scleroderma)Pulmonary involvement in systemic sclerosis (scleroderma)Progressive systemische Sklerodermie (Sklerose)Cardiovascular function in patients with progressive systemic sclerosis (scleroderma)The Interstitial Lung Diseases Associated with the Collagen-Vascular DisordersThe Prevalence of Conduction Defects and Cardiac Arrhythmias in Progressive Systemic SclerosisNIGEL K. ROBERTS, M.D., WILLIAM R. CABEEN Jr., M.D., JUDITH MOSS, R.N., PHILIP J. CLEMENTS, M.D., DANIEL E. FURST, M.D.Progressive Systemic Sclerosis: Pulmonary InvolvementSmall airways in progressive systemic sclerosis (PSS)Pulmonary Function in SclerodermaIdiopathic Pulmonary Fibrosis Clinical, Histologic, Radiographic, Physiologic, Scintigraphic, Cytologic, and Biochemical AspectsRONALD G. CRYSTAL, M.D., JACK D. FULMER, M.D., WILLIAM C. ROBERTS, M.D., MORTON L. MOSS, M.D., BRUCE R. LINE, M.D., HERBERT Y. REYNOLDS, M.D., F.A.C.P.Pathogenetic mechanisms of interstitial pulmonary fibrosis in patients with serum antinuclear factorVascular Disease in Progressive Systemic Sclerosis (Scleroderma)WALTER L. NORTON, M.D., F.A.C.P., JOHN M. NARDO, M.D.HRCT — Pathologic Correlations in Small Airways DiseasesAnalysis of twenty-seven cases of progressive systemic sclerosis (including two with combined systemic lupus erythematosus) and a review of the literaturePulmonary Involvement in Renal DiseaseThe Lungs in Systemic SclerosisLung Involvement in the Connective Tissue DisordersThe Pathophysiology of Scleroderma Involving the Heart and Respiratory SystemMARVIN A. SACKNER, M.D., NECATI AKGUN, M.D., PHILIP KIMBEL, M.D., DAVID H. LEWIS, M.D.An early pulmonary physiologic abnormality in progressive systemic sclerosis (diffuse scleroderma)Tramite pulmonaire de type silicotique sans silicosePulmonary Function in SclerodermaPulmonary Vascular Lesions in Systemic SclerodermaLung Function in Patients with Systemic SclerosisScleroderma and its oral manifestationsDermatomyositis with Cystic Fibrosis (Honeycombing) of the LungPulmonary fibrosis in rheumatic heart diseasePericardial effusion and cor pulmonale in progressive systemic sclerosis (Scleroderma)VALVULAR DISEASE OF THE HEART IN SYSTEMIC SCLERODERMA.THE HEART IN SCLERODERMAACUTE DIFFUSE INTERSTITIAL PULMONARY FIBROSIS IN SCLERODERMAPRIMARY INTERSTITIAL PULMONARY FIBROSIS: DIFFUSE AND CIRCUMSCRIBED FORMSMyokarditis und weitere MyokardiopathienCor pulmonaleCor pulmonaleHoneycomb Lungs and Malignant Pulmonary Adenomatosis in SclerodermaPulmonary Manifestations of Collagen DiseasesThe electrocardiogram in scleroderma: Analysis of 60 cases and review of the literatureCancer of the Lung in Progressive Systemic SclerosisElectrocardiograms of Ninety Patients with Acrosclerosis and Progressive Diffuse Sclerosis (Scleroderma)Spontaneous Pneumothorax in SclerodermaPericardial effusion in generalized sclerodermaDie progressive SklerodermieThe Pulmonary Manifestations of Generalised Scleroderma (Progressive Systemic Sclerosis)DIFFUSE INTERSTITIAL PULMONARY FIBROSIS*HENRY L. WILDBERGER, M.D., WILLIAM R. BARCLAY, M.D.SCLERODERMA AND DERMATOMYOSITIS.*Honeycomb Lung and Mitral Stenosis in SclerodermaDie progressive Sklerodermie und die dabei zu erhebenden R�ntgenbefundePulmonary FibrosisSCLERODERMA: RELATION OF PULMONARY CHANGES TO ESOPHAGEAL DISEASE*PETER R. MAHRER, M.D., JOHN A. EVANS, M.D., ISRAEL STEINBERG, M.D., F.A.C.P.Pulmonary fibrosis and terminal bronchiolar ("alveolar-cell") carcinoma in sclerodermaRHEUMATISM AND ARTHRITIS REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS (TENTH RHEUMATISM REVIEW)* Part IIWILLIAM D. ROBINSON, M.D., F.A.C.P., EDWARD W. BOLAND, M.D., F.A.C.P., JOSEPH J. BUNIM, M.D., F.A.C.P., DARRELL C. CRAIN, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., WALLACE GRAHAM, M.D., F.R.C.P. (C), L. MAXWELL LOCKIE, M.D., F.A.C.P., MAX M. MONTGOMERY, M.D., F.A.C.P., CHARLES RAGAN, M.D., F.A.C.P., MARIAN W. ROPES, M.D., F.A.C.P., EDWARD F. ROSENBERG, M.D., F.A.C.P., CHARLEY J. SMYTH, M.D.Progressive Systemic Sclerosis (Scleroderma)DIFFUSE INTERSTITIAL PULMONARY FIBROSIS CAMOUFLAGED BY HYPERMETABOLISM AND CARDIAC FAILURE: ANTEMORTEM DIAGNOSIS WITH BIOPSY AND CATHETERIZATION STUDIES*JACOB J. SILVERMAN, M.D., F.A.C.P., THEODORE J. TALBOT, M.D., F.A.C.P.Pulmonary Fibrosis in Generalized SclerodermaScleroderma heart diseaseDiffuse Interstitial Fibrosis of the LungsEffects of cortisone and ACTH in cases of chronic pulmonary disease with impairment of alveolar-capillary diffusionPATTERNS OF PULMONARY FIBROSIS AS RELATED TO PULMONARY FUNCTION*DAVID M. SPAIN, M.D. 1 January 1950Volume 32, Issue 1Page: 152-161KeywordsAnatomical pathologyLungsSclerodermaSurgeonsThorax ePublished: 1 December 2008 Issue Published: 1 January 1950 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
SPAIN et al. (1950) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: